Months after cancer drug trial, Merus agrees to be bought at 41% premium

1 month ago 14
ARTICLE AD BOX
Merus agreed to be bought for a 41% premium, months after a positive trial of a cancer drug.
Read Entire Article
  1. Homepage
  2. Finance
  3. Months after cancer drug trial, Merus agrees to be bought at 41% premium

Related

The U.K. just hiked its minimum wage again. Now it’s more than double the U.S.’s hourly pay floor.

The U.K. just hiked its minimum wage again. Now it’s more th...

1 hour ago 3
Dell rides a boom in AI servers to deliver an upbeat forecast

Dell rides a boom in AI servers to deliver an upbeat forecas...

10 hours ago 3
Urban Outfitters shares rally as turnaround at namesake stores pays off

Urban Outfitters shares rally as turnaround at namesake stor...

11 hours ago 4

Trending

Popular

Can Pidcock win big & why did it end at Ineos?

Can Pidcock win big & why did it end at Ineos?

8 months ago 386
Netflix scuttles plans to add six previously announced games to its service

Netflix scuttles plans to add six previously announced games...

9 months ago 344
‘I didn’t want to spend time with my children. I was just going through the motions’: the pain of parental burnout

‘I didn’t want to spend time with my children. I was just go...

9 months ago 337
‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided Beauty Standards Through Asian Eyes

‘Slanted’ Review: Extreme Makeover Satire Critiques Lopsided...

8 months ago 316
OpenAI co-founder John Schulman has left Anthropic after less than a year

OpenAI co-founder John Schulman has left Anthropic after les...

9 months ago 307
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Nexa News 2025. All rights are reserved